Type 3 Von Willebrand's Disease

Also known as: Von Willebrand Disease, Type 3 / Hereditary von Willebrand disease type 3 (disorder)

DrugDrug NameDrug Description
DB14473Beroctocog alfaBeroctocog alfa is indicated for the prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII (FVIII) deficiency. It is also indicated for surgical/invasive procedures in...
DB13133Von Willebrand factor humanA blood clotting factor used to manage bleeding episodes in von Willebrand disease and hemophilia A.
DrugDrug NamePhaseStatusCount
DB13923Emicizumab1Recruiting1
DB13133Von Willebrand factor humanNot AvailableActive Not Recruiting1